THERANOSTICS 2016* , ,
Presentations this author is a contributor to:
Safety and efficacy of peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTATATE and capecitabine as a radiosensitizer in metastatic neuroendocrine tumors (NETs) (#60)
8:30 AM
Ashwani Sood
Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours